Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Registry Study for Vibrant Hearing Solutions

NCT07906314 is registered in ClinicalTrials.gov with MED-EL Elektromedizinische Geräte GmbH as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07906314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Registry Study for Vibrant Hearing Solutions
Lead sponsor
MED-EL Elektromedizinische Geräte GmbH
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 26, 2026
Completion date
July 20, 2037
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conductive hearing loss, mixed hearing loss, sensorineural hearing loss, single sided deafness

Arms

As registered; 4 arms.

  • AMEI

    VSB

  • BCI

    BB

  • BCD

    Adhear

  • PMEI

    PMEI

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Patient reported hearing benefit Data may be analysed at predefined follow-up intervals corresponding to the following time periods after treatment: 0 to 3 months, >3 to 12 months, >12 to 24 months, >24 to 60 months, and beyond 60 months.

    Patient reported speech, spatial and qualities of hearing and auditory performance will be assessed by the Speech, Spatial, and Qualities of Hearing questionnaire (SSQ-12 or SSQ P).

Lead sponsor's other trials

MED-EL Elektromedizinische Geräte GmbH, most recent start first.

Similar trials

Same condition (Hearing Loss, Mixed Conductive-Sensorineural) and phase, most recent start first.